The investor day will again bring an international flavor. Nordic and Norwegian life science investors focusing on health, bioindustrials, sustainability and life science based solutions, will meet and partner 1:1 with life science companies and other investors.
The investor day will again bring an international flavor. Nordic and Norwegian life science investors focusing on health, bioindustrials, sustainability and life science based solutions, will meet and partner 1:1 with life science companies and other investors.
Last year’s conference brought ca 120 participants and 60+ 1:1 meetings between investors and companies.
Sustainable solutions across industries will require looking at solutions and needs from
different perspectives. Tightly linked to biology and biotechnology, digital solutions for
prevention, detection and treatment of disease have entered the stage. Also, AI and
machine learning have opened new possibilities in discovery, development and
documentation of new treatments and diagnostics. Bioindustrial solutions ensure a
sustainable utilization of resources for food and feed. How does this combine with the
regulatory landscape? How does investors look at the opportunities and challenges that
come with them?
The largest shifts are always innovation drivers.
Learn how Norwegian life science is well positioned to contribute to the next generation of solutions to UNs sustainable goals across health and bioindustrials.
This year’s partner is Inven2, Norway’s largest Tech Transfer Organization, owned by the University of Oslo and Oslo University Hospital, and serves as TTO for south-eastern parts of Norway.
Outline
Date & time: May 15th, 2024,
09.00 Coffee and registration
09.30-14.30 Investor and company talks
09.00-16.00 In-person and virtual 1:1 meetings, 30 minute timeslots
16.00 Afternoon rooftop reception with finger food and refreshments
Venue: Rooftop conference center Lyng in Forskningsparken will be a perfect venue with rooftop garden areas right outside. Oslo Science Park, Gaustadalléen 21, 0349 Oslo, Norway
Target audience:
Investors – Norwegian, Nordic and international
Norwegian life science companies in investable stage
Partnering platform: A link to the partnering system Hello!Partnering will be shared 2 weeks prior to the conference. Through this system, 1:1 meetings can be booked in advance.